Literature DB >> 25428873

Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.

Yuet Wu1, Wenwei Tu2, Kwok-Tai Lam1, Kin-Hung Chow3, Pak-Leung Ho3, Yi Guan4, Joseph S Malik Peiris4, Yu-Lung Lau2.   

Abstract

UNLABELLED: Secondary Streptococcus pneumoniae infection after influenza is a significant clinical complication resulting in morbidity and sometimes mortality. Prior influenza virus infection has been demonstrated to impair the macrophage and neutrophil response to the subsequent pneumococcal infection. In contrast, how a secondary pneumococcal infection after influenza can affect the adaptive immune response to the initial influenza virus infection is less well understood. Therefore, this study focuses on how secondary pneumococcal infection after influenza may impact the humoral immune response to the initial influenza virus infection in a lethal coinfection mouse model. Compared to mice infected with influenza virus alone, mice coinfected with influenza virus followed by pneumococcus had significant body weight loss and 100% mortality. In the lung, lethal coinfection significantly increased virus titers and bacterial cell counts and decreased the level of virus-specific IgG, IgM, and IgA, as well as the number of B cells, CD4 T cells, and plasma cells. Lethal coinfection significantly reduced the size and weight of spleen, as well as the number of B cells along the follicular developmental lineage. In mediastinal lymph nodes, lethal coinfection significantly decreased germinal center B cells, T follicular helper cells, and plasma cells. Adoptive transfer of influenza virus-specific immune serum to coinfected mice improved survival, suggesting the protective functions of anti-influenza virus antibodies. In conclusion, coinfection reduced the B cell response to influenza virus. This study helps us to understand the modulation of the B cell response to influenza virus during a lethal coinfection. IMPORTANCE: Secondary pneumococcal infection after influenza virus infection is an important clinical issue that often results in excess mortality. Since antibodies are key mediators of protection, this study aims to examine the antibody response to influenza virus and demonstrates that lethal coinfection reduced the B cell response to influenza virus. This study helps to highlight the complexity of the modulation of the B cell response in the context of coinfection.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25428873      PMCID: PMC4338877          DOI: 10.1128/JVI.02455-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

Review 1.  Marginal zone B cells.

Authors:  Shiv Pillai; Annaiah Cariappa; Stewart T Moran
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

2.  Virulence in mice of pneumococcal clonal types with known invasive disease potential in humans.

Authors:  Andreas Sandgren; Barbara Albiger; Carlos J Orihuela; Elaine Tuomanen; Staffan Normark; Birgitta Henriques-Normark
Journal:  J Infect Dis       Date:  2005-07-21       Impact factor: 5.226

3.  Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection.

Authors:  Lynnelle A McNamee; Allen G Harmsen
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

4.  Th cell-deficient mice control influenza virus infection more effectively than Th- and B cell-deficient mice: evidence for a Th-independent contribution by B cells to virus clearance.

Authors:  K Mozdzanowska; K Maiese; W Gerhard
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

5.  CCL5 modulates pneumococcal immunity and carriage.

Authors:  Ravichandran Palaniappan; Shailesh Singh; Udai P Singh; Rajesh Singh; Edwin W Ades; David E Briles; Susan K Hollingshead; Walter Royal; Jacquelyn S Sampson; Jonathan K Stiles; Dennis D Taub; James W Lillard
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

6.  CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection.

Authors:  Byung O Lee; Javier Rangel-Moreno; Juan E Moyron-Quiroz; Louise Hartson; Melissa Makris; Frank Sprague; Frances E Lund; Troy D Randall
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

7.  Virulence of Streptococcus pneumoniae in mice: a standardized method for preparation and frozen storage of the experimental bacterial inoculum.

Authors:  I S Aaberge; J Eng; G Lermark; M Løvik
Journal:  Microb Pathog       Date:  1995-02       Impact factor: 3.738

8.  Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza.

Authors:  Matthew W Smith; Jeffrey E Schmidt; Jerold E Rehg; Carlos J Orihuela; Jonathan A McCullers
Journal:  Comp Med       Date:  2007-02       Impact factor: 0.982

9.  The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice.

Authors:  Wenwei Tu; Jian Zheng; Yinping Liu; Sin Fun Sia; Ming Liu; Gang Qin; Iris H Y Ng; Zheng Xiang; Kwok-Tai Lam; J S Malik Peiris; Yu-Lung Lau
Journal:  J Exp Med       Date:  2011-06-27       Impact factor: 14.307

10.  Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection.

Authors:  Arnaud Didierlaurent; John Goulding; Seema Patel; Robert Snelgrove; Lionel Low; Magali Bebien; Toby Lawrence; Leonie S van Rijt; Bart N Lambrecht; Jean-Claude Sirard; Tracy Hussell
Journal:  J Exp Med       Date:  2008-01-28       Impact factor: 14.307

View more
  10 in total

1.  Viral Coinfection Replaces Effects of Suilysin on Streptococcus suis Adherence to and Invasion of Respiratory Epithelial Cells Grown under Air-Liquid Interface Conditions.

Authors:  Georg Herrler; Nai-Huei Wu; Peter Valentin-Weigand; Fandan Meng; Jie Tong; Désirée Vötsch; Ju-Yi Peng; Xuehui Cai; Maren Willenborg
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

2.  [Lower respiratory tract infection caused by influenza virus A and influenza virus B in Wenzhou, China: a clinical analysis of 366 children].

Authors:  Pei-Pei Zhong; Hai-Lin Zhang; Xiao-Fang Chen; Ya-Feng Liang; Li Lin; Shao-Yan Yang; Jiang-Yin Sheng; Chang-Chong Li
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2016-02

Review 3.  The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.

Authors:  Amber M Smith; Victor C Huber
Journal:  Viral Immunol       Date:  2017-11-17       Impact factor: 2.257

4.  COVID-19 Clinical Profiles and Fatality Rates in Hospitalized Patients Reveal Case Aggravation and Selective Co-Infection by Limited Gram-Negative Bacteria.

Authors:  Kamaleldin B Said; Ahmed Alsolami; Safia Moussa; Fayez Alfouzan; Abdelhafiz I Bashir; Musleh Rashidi; Rana Aborans; Taha E Taha; Husam Almansour; Mashari Alazmi; Amal Al-Otaibi; Luluh Aljaloud; Basmah Al-Anazi; Ahmed Mohialdin; Ahmed Aljadani
Journal:  Int J Environ Res Public Health       Date:  2022-04-26       Impact factor: 4.614

Review 5.  Next generation protein based Streptococcus pneumoniae vaccines.

Authors:  Michael E Pichichero; M Nadeem Khan; Qingfu Xu
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

6.  Immune-responsiveness of CD4+ T cells during Streptococcus suis serotype 2 infection.

Authors:  Marie-Pier Lecours; Corinne Letendre; Damian Clarke; Paul Lemire; Tristan Galbas; Marie-Odile Benoit-Biancamano; Jacques Thibodeau; Marcelo Gottschalk; Mariela Segura
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

7.  Highly specific and rapid glycan based amperometric detection of influenza viruses.

Authors:  Xikai Cui; Amrita Das; Abasaheb N Dhawane; Joyce Sweeney; Xiaohu Zhang; Vasanta Chivukula; Suri S Iyer
Journal:  Chem Sci       Date:  2017-02-14       Impact factor: 9.825

8.  IL-6 During Influenza-Streptococcus pneumoniae Co-Infected Pneumonia-A Protector.

Authors:  Xuemei Gou; Jun Yuan; Hong Wang; Xiaofang Wang; Jiangming Xiao; Jingyi Chen; Shuang Liu; Yibing Yin; Xuemei Zhang
Journal:  Front Immunol       Date:  2020-01-21       Impact factor: 7.561

Review 9.  Respiratory Barrier as a Safeguard and Regulator of Defense Against Influenza A Virus and Streptococcus pneumoniae.

Authors:  Kim S LeMessurier; Meenakshi Tiwary; Nicholas P Morin; Amali E Samarasinghe
Journal:  Front Immunol       Date:  2020-02-04       Impact factor: 7.561

10.  Influenza Virus Infects and Depletes Activated Adaptive Immune Responders.

Authors:  Caitlin D Bohannon; Zachary Ende; Weiping Cao; Wadzanai P Mboko; Priya Ranjan; Amrita Kumar; Margarita Mishina; Samuel Amoah; Shivaprakash Gangappa; Suresh K Mittal; Jonathan F Lovell; Adolfo García-Sastre; Blaine A Pfeifer; Bruce A Davidson; Paul Knight; Suryaprakash Sambhara
Journal:  Adv Sci (Weinh)       Date:  2021-06-30       Impact factor: 16.806

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.